相关实验视频

Updated: Jul 4, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

VentX促进瘤特异性免疫力和免疫检查点抑制剂的有效性

Yi Le¹, Hong Gao², Joanna Le³

¹Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

|February 1, 2024

概括

在与瘤相关的巨细胞中恢复VentX表达增强了非小细胞肺癌中抗PD-1疗法的疗效. 这种方法可以重新激活免疫细胞并改善治疗结果,而不会损害健康的肺细胞.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
癌症生物学癌症生物学

背景情况:

瘤微环境中的免疫抑制 (TME) 限制了免疫检查点抑制剂 (ICI) 在固体瘤中的有效性.
瘤相关巨细胞 (TAMs) 中降低的VentX表达有助于它们的细胞功能障碍,并影响TME的免疫状态.

研究的目的:

研究VentX在调节TAM功能和TME免疫力中的作用.
评估恢复VentX表达的潜力,以提高非小细胞肺癌 (NSCLC) 的抗PD-1疗法疗效.

主要方法:

利用了针对NSCLC的瘤免疫微环境启用模型系统 (TIME-EMS).
评估了PD-1抗体治疗与VentX恢复在TAMs中的影响.
采用了原始人类NSCLC的NSG-PDX模型中的体内数据.

主要成果:

单独的PD-1抗体显示了细胞毒性T淋巴细胞 (CTLs) 的适度激活,但没有改变TIME.
恢复TAM中的VentX表达恢复了它们的细胞活动,改变了TIME.
恢复VentX导致瘤特异性CTL激活,并增强PD-1抗体对NSCLC的疗效,对正常肺细胞没有毒性.

结论:

基于VentX的机制为克服TME免疫抑制提供了一个有希望的策略.
在TAM中恢复VentX可以增强ICI (如NSCLC治疗PD-1抗体) 的疗效.
向VentX为改善固体瘤ICI治疗提供了一个潜在的途径.

关键词:

癌症癌症癌症癌症免疫学免疫学免疫学分子生物学分子生物学

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...